Cystic Fibrosis Ireland – Irish Thoracic Society – Gilead Research Fellowship
The Irish Thoracic Society (ITS) in partnership with Cystic Fibrosis Ireland (CFI) is pleased to invite applications for a Research Fellowship kindly supported by Gilead UK and Ireland through an unrestricted educational grant.
Rules for the award
The fellowship would be funded with the objective of helping a young clinician with an interest in cystic fibrosis, who is in the early stages of his or her career, to carry out basic or clinical research projects and to develop, acquire, and apply advanced research procedures and techniques in the area of cystic fibrosis medicine and healthcare. Priority would be given to candidates who are members of Specialist Registrar programmes in Respiratory Medicine or Paediatric Medicine and who intend to register with a University for an MD (or equivalent) degree. Research projects must be carried out in the Republic of Ireland. Awards are conditional on the availability of appropriate facilities and resources in the host institution.
The amount of the fellowship is €133,120* (£95,000) to be administered over two years as ITS and CFI see fit. The fellowship is intended to contribute to the salary or consumable costs of the applicant during the course of a period of dedicated full time research. The fellowship is not granted for basic training, courses, lectures, meetings, conferences, congresses or for visiting institutions.
Awards are granted with the expectation that submissions for presentation will be made at appropriate medical conventions (eg ITS, American Thoracic Society, European Respiratory Society, British Thoracic Society, European Cystic Fibrosis Conference, North American Cystic Fibrosis Conference, etc) and abstracts/papers will be submitted for publication in appropriate medical journals. The successful candidate should acknowledge the Cystic Fibrosis Ireland – Irish Thoracic Society – Gilead Fellowship as a source of support in publications and presentations.
Selection will be made on the basis of scientific and expert evaluation of the application and the proposed work as set out by the candidates in the project description. Independent reviewers will be selected by the Committee of the Irish Thoracic Society (ITS) and Cystic Fibrosis Ireland (CFI) to carry out this task and the final decision will be made by the Committee of the Irish Thoracic Society/Cystic Fibrosis Ireland, with the assistance of the reviewers' assessments. Reviewers' assessments are strictly confidential and cannot be divulged outside the ITS or CFI, or to the candidates themselves.
The successful applicant will be required to submit an end-of-project report within a month of the end of the project. This report will be published on the ITS website.
(1) A detailed Project Description (see below)
This is the most important component of the application. It should be prepared by the candidate and have the approval of host supervisors. The description must not exceed 2500 words. It must address in sufficient scientific, medical and/or technical detail all of the following points:
b. Objectives and underlying hypothesis
c. Material, methods, procedures
d. Relevance to cystic fibrosis medicine and healthcare
e. Relevance and potential benefits to patients with cystic fibrosis
f. Relevance and potential benefits to activities in the host institution
g. Relationship to past, current and future professional activities
h. Reason(s) for choice of host institution
i. Reference to recent publications in the project field from the host and others, where applicable
(2) Current Curriculum Vitae, including publications and presentations
(3) One page summary of proposed use of the funding
(4) Letter of support from intended supervisor of project
(5) Two references from Consultants for whom you have worked in the past or at present
For further inquiries contact Suzanne McCormack, CEO, the Irish Thoracic Society:
Tel: +353 (0)1 2833500